Why the study?
Do serum lipid fractions affect the risk for microangiopathy in patients with type 2 diabetes mellitus?
Do serum lipid fractions affect the risk for microangiopathy in patients with type 2 diabetes mellitus?
Attaining established ADA goals for HDL-C, TG, and non-HDL-C may reduce the risk for microvascular events among patients with type 2 diabetes.
This study demonstrates significant independent associations among lipid fractions and risk for microangiopathy. These findings suggest that attaining established ADA goals for HDL-C, TG, and non-HDL-C may reduce risk for microvascular events among patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Tóth et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: